Dexcom (DC4) Q3 2023 Earnings Report
DE:DC4 Q3 2023 EPS Results
- Actual EPS
- EUR 0.45
- Consensus EPS
- EUR 0.30
- Beat/Miss
- Beat by +EUR 0.14
- One Year Ago EPS
- EUR 0.25
DE:DC4 Q3 2023 Revenue Results
- Actual Revenue
- EUR 870.09M
- Expected Revenue
- EUR 838.53M
- Beat/Miss
- Beat by +EUR 31.56M
- YoY Revenue Growth
- +26.69%
Earnings Announcement Details
- Quarter
- Q3 2023
- Date
- 10/26/2023
- Time
- After Close
- Conference Call
- Thursday, October 26, 2023
DE:DC4 Upcoming Earnings
Dexcom's next earnings date is estimated for February 11, 2027, based on past reporting schedules.
Q3 2023 Earnings Call Audio
DE:DC4 Q3 2023 Earnings Call
0:00 / 0:00
Q3 2023 Earnings Slide Deck
Q3 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:DC4 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 11, 2027 | 2026 (Q4) | 0.64- | 0.61 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 0.600.65 | 0.54 | 19.67% (+0.11) | |
| Jul 30, 2026 | 2026 (Q2) | 0.550.62 | 0.43 | 45.83% (+0.20) | |
| Apr 30, 2026 | 2026 (Q1) | 0.420.50 | 0.29 | 75.00% (+0.21) | |
| Feb 12, 2026 | 2025 (Q4) | 0.580.61 | 0.4 | 51.11% (+0.21) | |
| Oct 30, 2025 | 2025 (Q3) | 0.510.54 | 0.4 | 35.56% (+0.14) | |
| Jul 30, 2025 | 2025 (Q2) | 0.400.43 | 0.38 | 11.63% (+0.04) | |
| May 01, 2025 | 2025 (Q1) | 0.290.29 | 0.29 | 0.00% (+0.00) | |
| Feb 13, 2025 | 2024 (Q4) | 0.430.40 | 0.45 | -10.00% (-0.04) | |
| Oct 24, 2024 | 2024 (Q3) | 0.390.40 | 0.45 | -10.00% (-0.04) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed